Shenzhen Neptunus Interlong Bio-technique Company Limited

SZSE
8329
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Reporting Shenzhen Neptunus Interlong Bio-technique Company Limited

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
0.2819
Выручка, млрд ¥
1.07
Чистая прибыль, млрд ¥
0.0601
EV, млрд ¥
0.002
EBITDA, млрд ¥
0.1229


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
0.3501
Долг, млрд ¥
0.0927


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS 0.04


Efficiency

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 7.34 17.91
ROS, % 5.62 5.62 5.62 5.62 23.77 5.62 0.00
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % 11.49 11.49 28.48 11.49 0.00
Чистая рентаб, % 5.61 23.79
Operation Margin, % 0 0 0 0 0.00


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
4.32 33.38
P/BV
0.29 5.66
P/S
0.24 9.95
P/FCF
0 0 0 0 0.00
E/P
0.2132 0.2132 0.2132 0.2132 0.04 0.2132 0.00
EV/EBIT
0 0 0
EV/EBITDA
0.02 25.59
EV/S
0.0019 0.0019 0.0019 0.0019 9.50 0.0019 0.00
EV/FCF
0 0 0 0.00
Debt/EBITDA
0.7543 0.7543 0.7543 0.7543 0.59 0.7543 0.00
Netdebt/Ebitda
0 0 0 0 0.00
Debt/Ratio
0 0 0 0 0.00
Debt/Equity
0 0 0 0 0.00
Debt/Net Income
1.54 1.54 1.54 1.54 0.75 1.54 0.00
PEG
0 0
Бета
0 0 0 0 0.00
Индекс Альтмана
0 0 0 0 0.00


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденды / прибыль, %
0 29.29


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 CAGR 5
Персонал, чел
1 458 0.00